PubMed

Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis.

Kidd M, McKenzie SH, Steven I, Cooper C, Lanz R; Australian Ketotifen Study Group.

Br J Ophthalmol. 2003 Oct;87(10):1206-11.PMID: 14507747 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.

Crampton HJ.

Clin Ther. 2003 Jul;25(7):1975-87.PMID: 12946545 [PubMed - indexed for MEDLINE]Related articles

Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model.

Abelson MB, Chapin MJ, Kapik BM, Shams NB.

Arch Ophthalmol. 2003 May;121(5):626-30.PMID: 12742839 [PubMed - indexed for MEDLINE]Related articles

Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.

Borazan M, Karalezli A, Akova YA, Akman A, Kiyici H, Erbek SS.

Acta Ophthalmol. 2009 Aug;87(5):549-54. Epub 2008 Jul 9.PMID: 18631332 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population.

Abelson MB, Ferzola NJ, McWhirter CL, Crampton HJ.

Pediatr Allergy Immunol. 2004 Dec;15(6):551-7.PMID: 15610370 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis.

Greiner JV, Mundorf T, Dubiner H, Lonsdale J, Casey R, Parver L, Kapik BM, Shams NB, Abelson MB.

Am J Ophthalmol. 2003 Dec;136(6):1097-105.PMID: 14644221 [PubMed - indexed for MEDLINE]Related articles

Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.

Verin P, Easty DL, Secchi A, Ciprandi G, Partouche P, Nemeth-Wasmer G, Brancato R, Harrisberg CJ, Estivin-Ebrardt C, Coster DJ, Apel AJ, Coroneo MT, Knorr M, Carmichael TR, Kent-Smith BT, Abrantes P, Leonardi A, Cerqueti PM, Modorati G, Martinez M.

Am J Ophthalmol. 2001 Jun;131(6):691-8.PMID: 11384563 [PubMed - indexed for MEDLINE]Related articles

Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis: a real-world comparison of efficacy and ocular comfort.

Ganz M, Koll E, Gausche J, Detjen P, Orfan N.

Adv Ther. 2003 Mar-Apr;20(2):79-91.PMID: 12836808 [PubMed - indexed for MEDLINE]Related articles

Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.

Avunduk AM, Tekelioglu Y, Turk A, Akyol N.

Clin Ther. 2005 Sep;27(9):1392-402.PMID: 16291412 [PubMed - indexed for MEDLINE]Related articles

Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group.

Richard C, Trinquand C, Bloch-Michel E.

Eur J Ophthalmol. 1998 Oct-Dec;8(4):207-16.PMID: 9891891 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis.

Whitcup SM, Bradford R, Lue J, Schiffman RM, Abelson MB.

Clin Ther. 2004 Jan;26(1):29-34.PMID: 14996515 [PubMed - indexed for MEDLINE]Related articles

Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model.

D'Arienzo PA, Leonardi A, Bensch G.

Clin Ther. 2002 Mar;24(3):409-16.PMID: 11952024 [PubMed - indexed for MEDLINE]Related articles

Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.

Giede C, Metzenauer P, Petzold U, Ellers-Lenz B.

Curr Med Res Opin. 2000;16(3):153-63.PMID: 11191004 [PubMed - indexed for MEDLINE]Related articles

Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.

Spangler DL, Abelson MB, Ober A, Gotnes PJ.

Clin Ther. 2003 Aug;25(8):2245-67.PMID: 14512132 [PubMed - indexed for MEDLINE]Related articles

Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate.

Aguilar AJ.

Acta Ophthalmol Scand Suppl. 2000;(230):52-5.PMID: 11057352 [PubMed - indexed for MEDLINE]Related articles

Bioequivalence of two formulations of ketotifen fumarate ophthalmic solution: a single-center, randomized, double-masked conjunctival allergen challenge investigation in allergic conjunctivitis.

Torkildsen GL, Abelson MB, Gomes PJ.

Clin Ther. 2008 Jul;30(7):1272-82.PMID: 18691986 [PubMed - indexed for MEDLINE]Related articles

Ocular tolerability and safety of ketotifen fumarate ophthalmic solution.

Abelson MB, Chapin MJ, Kapik BM, Shams NB.

Adv Ther. 2002 Jul-Aug;19(4):161-9.PMID: 12431041 [PubMed - indexed for MEDLINE]Related articles

A comparison of the relative clinical efficacy of a single dose of ketotifen fumarate 0.025% ophthalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by the conjunctival allergen challenge model.

Crampton HJ.

Clin Ther. 2002 Nov;24(11):1800-8.PMID: 12501875 [PubMed - indexed for MEDLINE]Related articles

Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference.

Leonardi A, Zafirakis P.

Curr Med Res Opin. 2004 Aug;20(8):1167-73.PMID: 15324519 [PubMed - indexed for MEDLINE]Related articles

Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model.

Netland PA, Leahy C, Krenzer KL.

Am J Ophthalmol. 2000 Dec;130(6):717-23.PMID: 11124289 [PubMed - indexed for MEDLINE]Related articles